Antineoplastic AgentsRadiation DosageRadiation, IonizingRadiation InjuriesDose-Response Relationship, RadiationRadiation ToleranceRadiationDrug Screening Assays, AntitumorCell Line, TumorRadiation ProtectionRadiation MonitoringNeoplasmsDoxorubicinApoptosisDrug Resistance, NeoplasmRadiation OncologyCell SurvivalAntineoplastic Agents, PhytogenicCisplatinAntibiotics, AntineoplasticCosmic RadiationDrug Delivery SystemsRadiation Injuries, ExperimentalGamma RaysTumor Cells, CulturedRadiation PneumonitisDrug CarriersDNA DamageXenograft Model Antitumor AssaysNeoplasms, Radiation-InducedMice, NudeRadiation-Sensitizing AgentsRadiotherapyBackground RadiationEllipticinesCell ProliferationUltraviolet RaysDose-Response Relationship, DrugCombined Modality TherapyEtoposideRadiometryCamptothecinPaclitaxelRadiotherapy DosageTime FactorsDrug Resistance, MultipleInhibitory Concentration 50P-GlycoproteinRadiation EffectsMolecular StructureBreast NeoplasmsGenitalia, FemaleCell CycleDrug DesignDrug SynergismRadiation-Protective AgentsDNA Topoisomerases, Type IIProdrugsEnzyme InhibitorsDNA RepairFluorouracilAcute Radiation SyndromeGene Expression Regulation, NeoplasticSex CharacteristicsDrug Evaluation, PreclinicalTopoisomerase I InhibitorsPlant ExtractsDaunorubicinNanoparticlesNanomedicineTumor Suppressor Protein p53DNANeoplasms, ExperimentalPlatinumColonic NeoplasmsX-RaysAntimetabolites, AntineoplasticNeoplasm TransplantationSignal TransductionDrug DiscoveryNanocapsulesTreatment OutcomeRadioactive Hazard ReleaseSexual Behavior, AnimalCaspasesAntineoplastic Combined Chemotherapy ProtocolsCobalt RadioisotopesRadiotherapy, ConformalRadiobiologyModels, BiologicalOrganoplatinum CompoundsRadiation Hybrid MappingSex FactorsCaspase 3Cell DivisionBrain NeoplasmsProto-Oncogene Proteins c-bcl-2Antineoplastic Agents, AlkylatingBlotting, WesternMolecular Targeted Therapy